For Jasmine Jaffar, a 26-year-old who moved across the world to London, living in and exploring the city has turned every day into an adventure. Navigating this chapter in her life has brought her so many new experiences, but there’s always been one constant: her type 1 diabetes.

Discovering things about her new home came with many unknowns, including what her diabetes needs would look like with all her new routines and activities. A spontaneous team lunch, going to the gym after work, trying out a new food hotspot — everyday activities were often accompanied by many thoughts around how they would impact her glucose levels and insulin needs.

And while Jaffar carefully tracked her blood glucose, she couldn’t always predict how much insulin her body needed, and when. “Anything under the sun can impact your numbers,” said Jaffar, who grew up in Australia and moved from Sydney in 2020. “Sometimes, living with diabetes, you can feel like you’re playing catch-up, and like you’re more reactive with your management than proactive.”

That changed when modern diabetes technology came into her life.

Jaffar is one of many using a single smartphone app to keep tabs on her condition — managing her diabetes with the same convenience of scrolling social media or texting with friends.

The data from Novo Nordisk’s connected insulin pens, FreeStyle Libre’s LibreLink app and LibreView enables her to view glucose and insulin data together on a compatible smartphone. This helps her decide the proper amount of insulin needed each time, and prevents insulin stacking or confusion around dose times.

Our FreeStyle Libre integrates with different technologies that help make living with diabetes more manageable. Currently, FreeStyle Libre’s LibreLink app and LibreView app integration with Novo Nordisk is available in a number of countries: Austria, Belgium, Canada, Croatia, Czech Republic, Denmark, Finland, France, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland and the United Kingdom.

In Jaffar’s case, the integration of the two key devices takes away the need to constantly track her dosage on her own, providing her with more ease and flexibility. Access to her precise numbers also gives her doctors a more accurate picture of her condition.

“It takes such a weight off my shoulders to have that convenience,” she said.